Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis

被引:19
作者
Shen, Shanxiang [1 ]
Qin, Dahui [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA
关键词
EGFR; KRAS; BRAF; Pyrosequencing; Software; COLORECTAL-CANCER; LUNG-CANCER; GEFITINIB; THERAPY; PYROPHOSPHATE; CETUXIMAB; MELANOMA; COMMON; DETECT;
D O I
10.1186/1746-1596-7-56
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Pyrosequencing is a new technology and can be used for mutation tests. However, its data analysis is a manual process and involves sophisticated algorithms. During this process, human errors may occur. A better way of analyzing pyrosequencing data is needed in clinical diagnostic laboratory. Computer software is potentially useful for pyrosequencing data analysis. We have developed such software, which is able to perform pyrosequencing mutation data analysis for epidermal growth factor receptor, Kirsten rat sarcoma viral oncogene homolog and v-raf murine sarcoma viral oncogene homolog B1. The input data for analysis includes the targeted nucleotide sequence, common mutations in the targeted sequence, pyrosequencing dispensing order, pyrogram peak order and peak heights. The output includes mutation type and percentage of mutant gene in the specimen. Results: The data from 1375 pyrosequencing test results were analyzed using the software in parallel with manual analysis. The software was able to generate correct results for all 1375 cases. Conclusion: The software developed is a useful molecular diagnostic tool for pyrosequencing mutation data analysis. This software can increase laboratory data analysis efficiency and reduce data analysis error rate. Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1348911657684292.
引用
收藏
页数:9
相关论文
共 19 条
[1]   Single-nucleotide polymorphism analysis by pyrosequencing [J].
Ahmadian, A ;
Gharizadeh, B ;
Gustafsson, AC ;
Sterky, F ;
Nyrén, P ;
Uhlén, M ;
Lundeberg, J .
ANALYTICAL BIOCHEMISTRY, 2000, 280 (01) :103-110
[2]   Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].
Amado, Rafael G. ;
Wolf, Michael ;
Peeters, Marc ;
Van Cutsem, Eric ;
Siena, Salvatore ;
Freeman, Daniel J. ;
Juan, Todd ;
Sikorski, Robert ;
Suggs, Sid ;
Radinsky, Robert ;
Patterson, Scott D. ;
Chang, David D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634
[3]   Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].
Chapman, Paul B. ;
Hauschild, Axel ;
Robert, Caroline ;
Haanen, John B. ;
Ascierto, Paolo ;
Larkin, James ;
Dummer, Reinhard ;
Garbe, Claus ;
Testori, Alessandro ;
Maio, Michele ;
Hogg, David ;
Lorigan, Paul ;
Lebbe, Celeste ;
Jouary, Thomas ;
Schadendorf, Dirk ;
Ribas, Antoni ;
O'Day, Steven J. ;
Sosman, Jeffrey A. ;
Kirkwood, John M. ;
Eggermont, Alexander M. M. ;
Dreno, Brigitte ;
Nolop, Keith ;
Li, Jiang ;
Nelson, Betty ;
Hou, Jeannie ;
Lee, Richard J. ;
Flaherty, Keith T. ;
McArthur, Grant A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516
[4]   A Virtual Pyrogram Generator to Resolve Complex Pyrosequencing Results [J].
Chen, Guoli ;
Olson, Matthew Theodore ;
O'Neill, Alan ;
Norris, Alexis ;
Beierl, Katie ;
Harada, Shuko ;
Debeljak, Marija ;
Rivera-Roman, Keila ;
Finley, Samantha ;
Stafford, Amanda ;
Gocke, Christopher David ;
Lin, Ming-Tseh ;
Eshleman, James Richard .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (02) :149-159
[5]   Pyrosequencing, a method approved to detect the two major EGFR mutations for anti EGFR therapy in NSCLC [J].
Dufort, Sandrine ;
Richard, Marie-Jeanne ;
Lantuejoul, Sylvie ;
de Fraipont, Florence .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
[6]   Pyrosequencing method to detect KRAS mutation in formalin-fixed and paraffin-embedded tumor tissues [J].
Dufort, Sandrine ;
Richard, Marie-Jeanne ;
de Fraipont, Florence .
ANALYTICAL BIOCHEMISTRY, 2009, 391 (02) :166-168
[7]   Inhibition of Mutated, Activated BRAF in Metastatic Melanoma [J].
Flaherty, Keith T. ;
Puzanov, Igor ;
Kim, Kevin B. ;
Ribas, Antoni ;
McArthur, Grant A. ;
Sosman, Jeffrey A. ;
O'Dwyer, Peter J. ;
Lee, Richard J. ;
Grippo, Joseph F. ;
Nolop, Keith ;
Chapman, Paul B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) :809-819
[8]   Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection [J].
Ibrahem, Salih ;
Seth, Rashmi ;
O'Sullivan, Brendan ;
Fadhil, Wakkas ;
Taniere, Philippe ;
Ilyas, Mohammad .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2010, 91 (06) :500-505
[9]   K-ras mutations and benefit from cetuximab in advanced colorectal cancer [J].
Karapetis, Christos S. ;
Khambata-Ford, Shirin ;
Jonker, Derek J. ;
O'Callaghan, Chris J. ;
Tu, Dongsheng ;
Tebbutt, Niall C. ;
Simes, R. John ;
Chalchal, Haji ;
Shapiro, Jeremy D. ;
Robitaille, Sonia ;
Price, Timothy J. ;
Shepherd, Lois ;
Au, Heather-Jane ;
Langer, Christiane ;
Moore, Malcolm J. ;
Zalcberg, John R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17) :1757-1765
[10]   KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer [J].
Lièvre, A ;
Bachet, JB ;
Le Corre, D ;
Boige, V ;
Landi, B ;
Emile, JF ;
Côté, JF ;
Tomasic, G ;
Penna, C ;
Ducreux, M ;
Rougier, P ;
Penault-Llorca, F ;
Laurent-Puig, P .
CANCER RESEARCH, 2006, 66 (08) :3992-3995